Contact Us |
The Cellular Immunotherapy for Cancer Working Committee provides scientific oversight for studies related to the utilization and outcomes after CAR-T Cell therapies and other cellular immunotherapies. Studies that focus on specific outcomes, predictors of outcomes, and utilization of CAR-T Cells should be submitted to this committee.
Meetings are held annually during the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Anyone with interest or expertise in the focus area is encouraged to attend.
2021 Cellular Immunotherapy for Cancer Status Report
2020 Cellular Immunotherapy for Cancer Agenda2020 Cellular Immunotherapy for Cancer Minutes and 2020-2021 Overview Plan
2019 Autoimmune Diseases and Cellular Therapies Agenda
2019 Autoimmune Diseases and Cellular Therapies Minutes and 2019-2020 Overview Plan
2018 Autoimmune Diseases and Cellular Therapies Agenda2018 Autoimmune Diseases and Cellular Therapies Minutes and 2018-2019 Overview Plan
To view PDF documents you will need Adobe Reader.